Therefore, we have colabeled tissues with a mouse monoclonal antibody against MCAD in combination with polyclonal antibodies against GFAP, S100B, and DCX to investigate the identity of cells capable of fatty acid oxidation. Here, DCX is linked to medium chain acyl-CoA dehydrogenase deficiency.